Eisai Co Stock Performance
| ESALF Stock | USD 28.86 0.00 0.00% |
On a scale of 0 to 100, Eisai Co holds a performance score of 4. The firm shows a Beta (market volatility) of 0.76, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eisai Co's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eisai Co is expected to be smaller as well. Please check Eisai Co's treynor ratio, expected short fall, relative strength index, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Eisai Co's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Eisai Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent essential indicators, Eisai Co reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 248.7 B | |
| Total Cashflows From Investing Activities | -28.8 B |
Eisai |
Eisai Co Relative Risk vs. Return Landscape
If you would invest 2,600 in Eisai Co on December 19, 2024 and sell it today you would earn a total of 286.00 from holding Eisai Co or generate 11.0% return on investment over 90 days. Eisai Co is currently producing 0.2632% returns and takes up 4.2456% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than Eisai, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Eisai Co Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eisai Co's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Eisai Co, and traders can use it to determine the average amount a Eisai Co's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.062
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ESALF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.25 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Eisai Co is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eisai Co by adding it to a well-diversified portfolio.
Eisai Co Fundamentals Growth
Eisai Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Eisai Co, and Eisai Co fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eisai Pink Sheet performance.
| Return On Equity | 0.035 | |||
| Return On Asset | 0.0031 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 18.8 B | |||
| Shares Outstanding | 286.7 M | |||
| Price To Earning | 22.87 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 756.23 B | |||
| EBITDA | 96.78 B | |||
| Cash And Equivalents | 290.45 B | |||
| Total Debt | 94.89 B | |||
| Debt To Equity | 0.11 % | |||
| Book Value Per Share | 2,699 X | |||
| Cash Flow From Operations | 117.59 B | |||
| Earnings Per Share | 0.86 X | |||
| Total Asset | 1.24 T | |||
| Retained Earnings | 398.86 B | |||
| Current Asset | 467.84 B | |||
| Current Liabilities | 150.48 B | |||
About Eisai Co Performance
By analyzing Eisai Co's fundamental ratios, stakeholders can gain valuable insights into Eisai Co's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Eisai Co has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eisai Co has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Eisai operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11322 people.Things to note about Eisai Co performance evaluation
Checking the ongoing alerts about Eisai Co for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Eisai Co help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eisai Co had very high historical volatility over the last 90 days |
- Analyzing Eisai Co's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eisai Co's stock is overvalued or undervalued compared to its peers.
- Examining Eisai Co's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eisai Co's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eisai Co's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eisai Co's pink sheet. These opinions can provide insight into Eisai Co's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Eisai Pink Sheet analysis
When running Eisai Co's price analysis, check to measure Eisai Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eisai Co is operating at the current time. Most of Eisai Co's value examination focuses on studying past and present price action to predict the probability of Eisai Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eisai Co's price. Additionally, you may evaluate how the addition of Eisai Co to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |